These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 33177717)

  • 21. N- and C-terminal regions of αB-crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation.
    Selig EE; Zlatic CO; Cox D; Mok YF; Gooley PR; Ecroyd H; Griffin MDW
    J Biol Chem; 2020 Jul; 295(29):9838-9854. PubMed ID: 32417755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of α-Synuclein Fibril Elongation by Hsp70 Is Governed by a Kinetic Binding Competition between α-Synuclein Species.
    Aprile FA; Arosio P; Fusco G; Chen SW; Kumita JR; Dhulesia A; Tortora P; Knowles TP; Vendruscolo M; Dobson CM; Cremades N
    Biochemistry; 2017 Mar; 56(9):1177-1180. PubMed ID: 28230968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chaperone-Mediated Protein Disaggregation Triggers Proteolytic Clearance of Intra-nuclear Protein Inclusions.
    den Brave F; Cairo LV; Jagadeesan C; Ruger-Herreros C; Mogk A; Bukau B; Jentsch S
    Cell Rep; 2020 Jun; 31(9):107680. PubMed ID: 32492414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The binding of the small heat-shock protein αB-crystallin to fibrils of α-synuclein is driven by entropic forces.
    Scheidt T; Carozza JA; Kolbe CC; Aprile FA; Tkachenko O; Bellaiche MMJ; Meisl G; Peter QAE; Herling TW; Ness S; Castellana-Cruz M; Benesch JLP; Vendruscolo M; Dobson CM; Arosio P; Knowles TPJ
    Proc Natl Acad Sci U S A; 2021 Sep; 118(38):. PubMed ID: 34518228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.
    Lo Bianco C; Shorter J; Régulier E; Lashuel H; Iwatsubo T; Lindquist S; Aebischer P
    J Clin Invest; 2008 Sep; 118(9):3087-97. PubMed ID: 18704197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling].
    Galvagnion C; Buell AK
    Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159
    [No Abstract]   [Full Text] [Related]  

  • 27. DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease.
    Ahmad A
    Int J Biol Macromol; 2010 Mar; 46(2):275-9. PubMed ID: 20060408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein Disaggregation in Multicellular Organisms.
    Nillegoda NB; Wentink AS; Bukau B
    Trends Biochem Sci; 2018 Apr; 43(4):285-300. PubMed ID: 29501325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsp110 mitigates α-synuclein pathology in vivo.
    Taguchi YV; Gorenberg EL; Nagy M; Thrasher D; Fenton WA; Volpicelli-Daley L; Horwich AL; Chandra SS
    Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24310-24316. PubMed ID: 31685606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration.
    Ziaunys M; Sakalauskas A; Mikalauskaite K; Smirnovas V
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsp70 molecular chaperones and Parkinson's disease.
    Witt SN
    Biopolymers; 2010 Mar; 93(3):218-28. PubMed ID: 19768775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular Handling of Protein Aggregates by Disaggregation Machines.
    Mogk A; Bukau B; Kampinga HH
    Mol Cell; 2018 Jan; 69(2):214-226. PubMed ID: 29351843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Hsp70 binding and nucleotide exchange by the yeast Hsp110 chaperone Sse1.
    Shaner L; Sousa R; Morano KA
    Biochemistry; 2006 Dec; 45(50):15075-84. PubMed ID: 17154545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.
    Pemberton S; Madiona K; Pieri L; Kabani M; Bousset L; Melki R
    J Biol Chem; 2011 Oct; 286(40):34690-9. PubMed ID: 21832061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein.
    Falsone SF; Kungl AJ; Rek A; Cappai R; Zangger K
    J Biol Chem; 2009 Nov; 284(45):31190-9. PubMed ID: 19759002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.
    Roodveldt C; Bertoncini CW; Andersson A; van der Goot AT; Hsu ST; Fernández-Montesinos R; de Jong J; van Ham TJ; Nollen EA; Pozo D; Christodoulou J; Dobson CM
    EMBO J; 2009 Dec; 28(23):3758-70. PubMed ID: 19875982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid Fragmentation and Disaggregation in Yeast and Animals.
    Kushnirov VV; Dergalev AA; Alexandrov AI
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.